Related Experiment Video

Updated: May 8, 2026

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

Differences between younger and older patients with childhood hodgkin lymphoma

Apostolos Pourtsidis1, Dimitrios Doganis, Margarita Baka

  • 1Oncology Department, "P & A. Kyriakou" Children's Hospital, Athens, Greece. tolisp@otenet.gr

Pediatric Hematology and Oncology
|August 15, 2013
PubMed

Insights

This study on pediatric Hodgkin

Area of Science:

  • Pediatric Oncology
  • Hematology
  • Clinical Research

Background:

  • Hodgkin's lymphoma (HL) is a cancer of the lymphatic system.
  • Pediatric HL treatment has evolved, necessitating age-specific outcome analysis.
  • Understanding age-related differences in HL is crucial for tailored treatment strategies.

Purpose of the Study:

  • To compare treatment outcomes and disease characteristics of pediatric Hodgkin's lymphoma based on age.
  • To identify age-specific prognostic factors in pediatric Hodgkin's lymphoma.

Main Methods:

  • Retrospective analysis of 74 pediatric Hodgkin's lymphoma patients treated between 1979 and 2006.
  • Patients were stratified into two age groups: younger than 8 years and 8 years or older.
  • Outcomes including disease stage, relapse rates, survival, and secondary malignancies were analyzed.

Main Results:

  • A total of 74 children were analyzed; 15 were younger than 8 and 59 were 8 or older.
  • Advanced stage disease was observed in 40% of younger patients and 44% of older patients.
  • Relapse rates were 20% in younger patients versus 8.5% in older patients, with all younger patients surviving compared to three deaths in the older group. Male predominance was noted in the younger cohort.

Conclusions:

  • While advanced stage disease and relapse rates varied, younger children with Hodgkin's lymphoma demonstrated favorable survival outcomes.
  • Age appears to be a significant factor influencing Hodgkin's lymphoma prognosis in pediatric patients.
  • Further research into age-specific treatment protocols is warranted for optimizing pediatric Hodgkin's lymphoma care.

More Related Videos

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma08:53

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...